Zweiman B: Mast cells in human disease. Clin Rev Allergy 1983; 1: 417-426.

Marone G, Casolaro V, Grillo R, et al: Pathophysiology of human basophils and mast cells in allergic disorders. Clin Immunol Immunopathol 1989; 50: 824-840.

https://doi.org/10.1016/0090-1229(89)90111-6

Siraganian RP: Mast cells and basophils. In: Gallin JI, Goldstein IM, Snyderman R (Eds): Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, 1988, pp. 513- 536.

Ishizaka K, Tomioka H, Ishizaka T: Mechanisms of passive sensitización: I. Presence of IgE and IgG molecules on human leukocytes. J Immunol 1970; 105: 1459-1467.

Urnas B: Chemistry and storage function of mast cell granules J Invest Dermatol 1978; 71: 76-80.

https://doi.org/10.1111/1523-1747.ep12544425

Eady RAJ: The mast cell in diseases of the skin. In Pepys J, Edwards AM (Eds): The Mast Cell. Tumbridge Wells, England, Pitman Medical, 1979 pp 544-549.

Tharp MD, Glass M, Seeling LL Jr: Ultraestructural morphometric analysis of lesional skin: Mast cells from patients with systemic and non systemic mastocytosis. J Am Acad Dermatol 1988; 18: 298-306.

https://doi.org/10.1016/S0190-9622(88)70043-2

Holgate ST, Kay AB; Mast cells, mediators and asthma. Clin Allergy 1985; 15: 221-234.

https://doi.org/10.1111/j.1365-2222.1985.tb02279.x

Eliakim R, Gilead L, Ligumsky M et al: Histamine and chondroitin sulfate E proteoglycan released by cultured colonic mucosa: Indication for possible presence of E mast cells, Proc Natl Acad Sci USA 1986; 83: 461-464.

https://doi.org/10.1073/pnas.83.2.461

Shanahan F, Denburg JA, Fox J, et al: Mast cell heterogeneity; Effects of neuroenteric peptides on histamine release. J Immunol 1985; 135: 1331-1337.

Razin E, Stevens RL, Akiyama F, et al: Culture from mouse bone marrow of a subclase of mast cells possesing a distinct chondroitin sulfate proteoglycan with glycosaminogycans rich in N-acetylgalactosamine-6,6-disulfate. J Biol Chem 1982; 257: 7229- 7236.

Tharp MD: IgE and Immediate Hypersensibility. Dermatologic Clinics 1990; 8: 619-631.

https://doi.org/10.1016/S0733-8635(18)30450-9

Kerdel FA, Soter NA: The mast cell in mastocytosis and pediatric dermatologic disease. Adv Dermatol 1989; 4: 159-182.

Keahey TM: The Pathogenesis of Urticaria. Dermatologic Clinics 1985; 3: 13-28.

https://doi.org/10.1016/S0733-8635(18)30915-X

Arrang JM, Garbarg M, Lancelot JC, et al: Highly potent and selective ligands for Histamine H3-receptors. Nature.- 1987; 327: 117-123.

https://doi.org/10.1038/327117a0

Beaven MA: Histamine. N. Engl J Med 1976; 294: 30-36.

https://doi.org/10.1056/NEJM197601012940108

Anwar ARE, Kay AB: The ECF-A tetrapeptides and histamine selectivity enhance human eosinophil complement receptors. Nature 1977; 269: 522-524.

https://doi.org/10.1038/269522a0

Lawrence ID, Warner JA, Cohan VL, et al: Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. J Immunol 1987; 139: 3062-3069.

Cawley EP. Hoch-Ligeti C: Association of tissue mast cells and¡ skin tumors. Arch Dermatol 1961; 83: 92-96.

https://doi.org/10.1001/archderm.1961.01580070098010

Jackson N, Burt D, Crocker J, et al; Skin mast cells in polycythaemia vera: Relationship to the pathogenesis and treatment of pruritus. Br J Dermatol 1987; 116: 21-29.

https://doi.org/10.1111/j.1365-2133.1987.tb05787.x

Glowacki J, Mulliken JB: Mast cells in hemangiomas and vascular malformations. Pediatrics 1982; 70: 48-51.

Hawkins RA, Claman HN, Clark RFA, et al: Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med 1985; 102: 182-186.

https://doi.org/10.7326/0003-4819-102-2-182

Lewis RA: Mastocytosis. J Allergy Clin Immunol 1984; 74:755-765.

https://doi.org/10.1016/0091-6749(84)90172-6

Sagher F, Even-Paz Z: Mastocytosis and the mast cell. Basel S Karger AG, 1967.

Rockoff AS: Urticaria pigmentosa in identical twins. Arch Dermatol 1978; 114: 1227-1228.

https://doi.org/10.1001/archderm.1978.01640200079024

Tharp MD, Chakcr B, Glass MJ, et al: In vitro functional reactivities of cutaneous mast cells from patients with mastocytosis. J Invest Dermatol 1987; 89: 264-268.

https://doi.org/10.1111/1523-1747.ep12471299

Homy HP, Parwaresch MR, Lennert K: Bone marrow findings in systemic mastocytosis. Hum Pathol 1985; 16: 808-814.

https://doi.org/10.1016/S0046-8177(85)80252-5

Caplan RM: The natural course of urticaria pigmentosa. Arch Dermatol 1963; 87: 56-67.

https://doi.org/10.1001/archderm.1963.01590140008002

Fishman RS, Fleming CR, Chin-Yang L: Systemic mastocytosis with review of gastrointestinal manifestations. Mayo Clin Proc 1979; 54: 51-54.

Fenske NA, LoberCW, Pautler SE:Congenital bullous urticaria pigmentosa. Treatment with concomitant use of Hi and H2 receptor antagonists. Arch Dermatol 1985; 121: 115-118.

https://doi.org/10.1001/archderm.1985.01660010119035

Czametzki BM: A double blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatológica 1983; 166: 44-47.

https://doi.org/10.1159/000249832

Roberts LJ, Sweetman BJ, Lewis RA, et al: Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Eng J Med 1980; 30: 383-40.

Barton J, Lavker RM, Schechter NM et al: Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985; 121: 1516-1523.

https://doi.org/10.1001/archderm.1985.01660120042017

Alexander RR: Disodium chromoglycate in the treatment of systemic mastocytosis involving only bone. Acta Haematol (Basel), 1985; 74: 108-110.

https://doi.org/10.1159/000206179

Vella Briffa D, Eady RAJ, James MP, et al: Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol 1983; 109: 67-75.

https://doi.org/10.1111/j.1365-2133.1983.tb03994.x

Fairley JA, Pentland AP, Voorhees JJ; Urticaria pigmentosa responsive to nifedipine. J Am Acad Dermatol 1984; 11: 740-743.

https://doi.org/10.1016/S0190-9622(84)70233-7